This makes complete sense from an investor’s perspective, as it increases the chances of a successful exit. While we focus on the technical merits or critique here on HN/YC, investors are playing a completely different game.
To be a bit acerbic, and inspired by Arthur C. Clarke, I might say: "Any sufficiently complex business could be indistinguishable from Theranos".